Back to CS Candriam S.C.A.
KRYS
5 quarters
Position history for CSCandriam S.C.A.'s holdings in Krystal Biotech, Inc.
No. Candriam S.C.A. exited its KRYS (Krystal Biotech) position in Q1 2024. Its Q4 2023 13F listed 55,000 shares worth $6.8M. Candriam S.C.A. first reported KRYS in Q1 2023 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$6.8M
Total Shares Change
-92,000
Quarter-by-Quarter History
Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC